NYSE:MDT - New York Stock Exchange, Inc. - IE00BTN1Y115 - Common Stock - Currency: USD
MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier.
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U.S. President Donald Trump's tariff plans, a company executive told Reuters on Tuesday. The company, whose products range from insulin pumps to surgical robots, has been closely monitoring Trump's tariff plans due to its presence in Mexico. The country houses the device maker's third largest manufacturing facility, according to its latest annual report.
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
/PRNewswire/ -- For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global leader in healthcare...
Mentions: JNJ
A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock. Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) are two very healthy, high-yielding dividend stocks. Medtronic currently has a 3.1% dividend yield.
Mentions: JNJ
Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news
The medical device maker has been a huge winner for its long-term shareholders.
Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off.
The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns.
The S&P 500 gained 0.2% on Tuesday, Feb. 18, 2025, posting a record close to kick off an abbreviated trading week that will see the release of the Fed's latest meeting minutes.
Medtronic (MDT) reported fiscal third-quarter revenue below analyst projections as some distributors
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday.
Major U.S. indexes wavered between gains and losses at midday Tuesday ahead of fresh economic data due later in the week.
Medtronic shares slumped Tuesday after the medical device maker missed sales forecasts.
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MDT delivers strong earnings in the fiscal 2025 third quarter, with significant improvements in both gross and operating margins.
The company reported fiscal third-quarter earnings and, on at least one metric, disappointed investors.
These are the stocks posting the largest moves in premarket trading.
Medtronic (MDT) delivered earnings and revenue surprises of 2.21% and 0.43%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Medtronic beat Wall Street estimates for quarterly profit on Tuesday, on strong demand for its heart and diabetes devices. Investors have high expectations of medical device makers as they continue to benefit from healthy demand for non-urgent surgeries, especially among older Americans, over the last few quarters. The company, however, kept its annual profit forecast unchanged in the range of $5.44 to $5.50 per share.
Today, several major companies are expected to report earnings: Baidu (BIDU), Cadence Design (CDNS), Devon Energy (DVN), Medtronic (MDT), MFA Fi...